Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Facade of AstraZeneca's office in Shanghai, China

Drug pricing

AstraZeneca Becomes Second Pharma to Strike DTC Deal With Trump Administration

The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in response to the president’s calls to lower U.S. drug prices.

October 10, 2025

1 min read

Dan Samorodnitsky

South side and Dome of the US Capitol in Washington DC, United States

BIOSECURE Act

The BIOSECURE Act Is Back, as Congress Tacks New Version On to Broader Defense Bill

A new version of the controversial bill removes the specific company names that were included in a previous iteration but still requires the industry to ditch Chinese biotech contractors in order to receive federal dollars.

October 10, 2025

1 min read

Annalee Armstrong

External view of Bristol Myers Squibb's office California

Mergers & acquisitions

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover

Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they “continue to look for more” from Bristol Myers Squibb before they can “get excited about the near term turnaround story.”

October 10, 2025

2 min read

Tristan Manalac

Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.

Gene therapy

AviadoBio Looks to China for Eye-Based Gene Therapy in $413M UgeneX Pact

AviadoBio will have the option to exclusively license UGX-202, a vision-restoring gene therapy for the rare eye condition retinitis pigmentosa.

October 10, 2025

2 min read

Tristan Manalac

President Donald Trump signs S.1852, The GENIUS Act, Friday, July 18, 2025, in the East Room of the White House. (Official White House Photo by Daniel Torok)

Drug pricing

GoodRx Wants In on Direct-to-Consumer TrumpRx Platform

GoodRx, an online platform that offers drug discount coupons to patients, is in talks with the government to participate in the forthcoming TrumpRx program.

October 10, 2025

2 min read

Tristan Manalac

Protection From Tariffs as an An umbrella that shields against import and export tariff taxes as a trade war storm increasing prices and straining supply chains as a business metaphor and a symbol for resilience in times of crisis and economic downturn.

Policy

NHS Mulls Greater Pharma Spending to Head Off Trump’s Tariffs: Report

The British proposal to increase support for pharma is “clearly positive,” according to analysts at Leerink, who noted that the NHS’ move will improve patient access to treatments.

October 10, 2025

2 min read

Tristan Manalac

Illustration showing a handshake, signaling cooperation, goodwill

Mergers & Acquisitions

Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space

Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the indication earlier this year.

October 9, 2025

2 min read

Annalee Armstrong

2006 James Gathany Captured by James Gathany, Centers for Disease Control's biomedical photographer, this 2006 image depicted the exterior of the new "Tom Harkin Global Communications Center", otherwise known as Building 19, located on the organization's Roybal Campus in Atlanta, Georgia. The facility houses the CDC's Information Center/Library, auditoria and meeting halls, which are used to accommodate in-house staff meetings, and national/international conferences hosted by the CDC, and the National Center for Health Marketing's, Division of Creative Services, which includes a full service television broadcast facility. The exhibit area currently features the "Global Symphony", the first of several permanently installed exhibitions, and changing exhibitions that focus on a variety of public health topics. The exhibits in the Center are self-guided, and require no advance reservations. Additional curriculum-based exhibits and programming will be added in the future. Tom Harkin Global Communications Center Exhibit Area Centers for Disease Control and Prevention - 1600 Clifton Road, N.E., Atlanta, Georgia 30333 - Hours: Monday Friday, 9 am 5 pm, except for federal holidays Admission is free - Government-issue photo ID is required for entry. Please note that CDC is a working federal facility and as such does not provide public tours of its campus and laboratories. - For more information please call 404-639-0830.

Vaccines

ACIP Meeting Delayed Indefinitely; COVID-19 Vaccines Continue To Show Benefit in New Study

The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been postponed, with no new date specified. The delay comes as the VA published new research showing that COVID-19 shots prevented hospitalizations and death.

October 9, 2025

2 min read

Tristan Manalac